Ann Dermatol.
2021 Dec;33(6):593-594. 10.5021/ad.2021.33.6.593.
Severe Psoriasis Successfully Treated with Brodalumab after Eradication of Hepatitis C Virus with Glecaprevir and Pibrentasvir: A Case Report
- Affiliations
-
- 1Department of Dermatology, Nippon Medical School, Tokyo, Japan
- 2Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan
- 3Department of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan
- KMID: 2522144
- DOI: http://doi.org/10.5021/ad.2021.33.6.593
Abstract
- no abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Comparison of Glecaprevir/Pibrentasvir and Sofosbuvir/Ledipasvir in Patients with Hepatitis C Virus Genotype 1 and 2 in South Korea
- Management of hepatitis C viral infection in chronic kidney disease patients on hemodialysis in the era of direct-acting antivirals
- Prevention of Viral Hepatitis and Vaccination
- Association of Hepatitis B Virus Infection and Psoriasis
- Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment
